glp-1-receptoragonister GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists in the
Description
Onset timeline Most cases of retatrutide skin sensitivity appear within the first 2 to 6 weeks of starting treatment, often coinciding with dose escalation phases
Heres what that means for health care Lauren J
Compared to placebo, it has been shown to significantly lower HbA1c by up to 2.07% when administered as a once-weekly subcutaneous injection at a maximum dose of 15 mg
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which typically diminish over time
